Table 1.
Characterization of asthmatic children compared to non-asthma control subjects
| Parameters | Control | Asthma | P value |
|---|---|---|---|
| Age (years) |
13.5 ± 4.2 |
13.7 ± 2.9 |
0.81 |
| BMI (kg/m2) |
21.1 ± 5.5 |
21.3 ± 6.6 |
0.81 |
| Waist circumference (cm) |
66.6 ± 15.1 |
70.7 ± 17.1 |
0.09 |
| Hip circumference (cm) |
82.1 ± 20.7 |
83.8 ± 19.9 |
0.54 |
| SAD (cm) |
17.0 ± 7.5 |
17.7 ± 19.6 |
0.53 |
| Cholesterol (mmol/l) |
4.3 ± 0.88 |
4.1 ± 0.72 |
0.07 |
| Glucose (mmol/l) |
5.3 ± 1.7 |
5.3 ± 1.7 |
0.90 |
| HDL-Cholesterol (mmol/l) |
1.04 ± 0.34 |
0.90 ± 0.31 |
0.008 |
| Triglycerides (mmol/l) |
1.1 ± 0.60 |
1.03 ± 0.41 |
0.59 |
| LDL-Cholesterol (mmol/l) |
2.8 ± 0.80 |
2.7 ± 0.67 |
0.21 |
| IgE (pg/ml) |
61.1 ± 4.3 |
123.1 ± 5.0 |
0.004 |
| Resistin (pg/ml) |
17.3 ± 1.3 |
24.5 ± 1.6 |
<0.001 |
| GMCSF (pg/ml) |
1.9 ± 0.10 |
1.0 ± 0.11 |
0.003 |
| INF-gamma (pg/ml) |
2.4 ± 0.74 |
1.6 ± 0.63 |
0.03 |
| IL4 (pg/ml) |
9.2 ± 1.4 |
18.5 ± 3.6 |
0.003 |
| IL5 (pg/ml) |
0.92 ± 0.20 |
0.52 ± 0.17 |
<0.001 |
| IL8 (pg/ml) |
12.4 ± 1.8 |
6.3 ± 1.2 |
0.004 |
| IL10 (pg/ml) |
12.1 ± 1.7 |
9.2 ± 1.4 |
0.03 |
| Naphthalene (ng/ml) |
10.7 ± 2.7 |
26.2 ± 2.5 |
<0.001 |
| Anthracene (ng/ml) |
239.5 ± 22.6 |
260.1 ± 52.3 |
0.79 |
| Fluorene (ng/ml) |
2.5 ± 0.75 |
3.6 ± 0.90 |
0.04 |
| Phenanthrene (ng/ml) |
9.3 ± 1.7 |
11.5 ± 1.9 |
0.13 |
| 4H-cyclobenta[def]phenanthrene (ng/ml) |
6.2 ± 1.1 |
20.3 ± 2.1 |
<0.001 |
| Pyrene (ng/ml) |
0.67 ± 0.34 |
1.1 ± 0.50 |
0.04 |
| Flouranthene (ng/ml) |
26.9 ± 3.2 |
31.8 ± 3.4 |
0.60 |
| 1,2-benzanthracene (ng/ml) |
0.37 ± 0.24 |
0.73 ± 0.36 |
0.01 |
| Chrysene (ng/ml) |
0.87 ± 0.19 |
1.8 ± 0.13 |
0.001 |
| Benzo(e)pyrene (ng/ml) |
1.6 ± 0.17 |
2.6 ± 0.20 |
0.32 |
| Benzoacephenanthrylene (ng/ml) |
1.7 ± 0.23 |
7.0 ± 0.90 |
0.006 |
| Benzo(a)pyrene (ng/ml) | 2.1 ± 0.80 | 4.8 ± 0.93 | 0.02 |